Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34
Anastasia Pyriochou(University of Patras), Andreas Papapetropoulos(National and Kapodistrian University of Athens)
Cited by 60
Related Papers
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
|British Journal of Pharmacology|2023|442
Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (<scp>CBS</scp>) and cystathionine γ lyase (<scp>CSE</scp>)
|British Journal of Pharmacology|2013|395
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
|British Journal of Pharmacology|2021|384
The role of H2S bioavailability in endothelial dysfunction
|Trends in Pharmacological Sciences|2015|160
Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway
|Cardiovascular Research|2015|80